2 pieces

Sharps Technology, Inc. has secured a significant deal with Stericare Solutions, LLC, agreeing to supply 520 million units of their 10ml PP Sologard syringes over five years, with an expected revenue of over $50 million. The supply will commence with an initial delivery targeted for November 2024 and features an automatic renewal clause for additional one-year terms. The deal not only represents a lucrative arrangement but also fully commits the company’s EU manufacturing capacity for the product, highlighting Sharps Technology’s growing impact in the medical supply industry.